Paper20108024
Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.
Suda K and 2 others. Cancer Metastasis Rev, 2010. Cited by 182 papers, by iCite.
Cite this record
ConductScience Library. Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Papers, record 20108024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20108024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Genes, erbB-1 | Major topic |
| Genes, ras | Major topic |
| Lung Neoplasms | Major topic |
| Mutation | Major topic |
| Animals | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Models, Biological | |
| Transcriptional Activation |
Source PubMed
Cited by96
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511913 | Unsupervised Deep Representation Learning and Probabilistic Clustering for the Systems-Level Discovery of Germline Mutation Signatures in Pediatric Cancers. | Biomedicines | 2026 | https://conductscience.org/library/papers/42511913 | PubMed |
| 41963365 | Extracellular matrix-driven patient stratification and network modeling reveal distinct molecular grades with potential clinical implications. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/41963365 | PubMed |
| 41595602 | A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer. | Biomedicines | 2025 | https://conductscience.org/library/papers/41595602 | PubMed |
| 41509216 | Revealing the Drivers Underlying Distinct Evolutionary Trajectories in Lung Adenocarcinoma. | bioRxiv | 2025 | https://conductscience.org/library/papers/41509216 | PubMed |
| 41162968 | BRCAGenie: A machine learning-driven 43-gene polygenic risk score model for precision prediction of breast cancer survival. | J Transl Med | 2025 | https://conductscience.org/library/papers/41162968 | PubMed |
| 41031439 | Fraternal cooperation of hierarchical cancer parallels metazoan multicellularity and eusociality. | Biol Rev Camb Philos Soc | 2026 | https://conductscience.org/library/papers/41031439 | PubMed |
| 41002380 | TIMP-1 Modulation Correlates with KRAS Dependency and EMT Induction in NSCLC. | Cells | 2025 | https://conductscience.org/library/papers/41002380 | PubMed |
| 40282505 | Alternative Splicing in Lung Adenocarcinoma: From Bench to Bedside. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282505 | PubMed |
| 40218244 | Lung Adenocarcinoma Exhibiting Thanatosomes (Hyaline Bodies), Cytoplasmic Clearing, and Nuclear Pleomorphism, with a KRAS Mutation. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40218244 | PubMed |
| 39926430 | Gene mutation in diabetic patients with lung adenocarcinoma: a real-world retrospective cohort study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/39926430 | PubMed |
| 39203962 | Tumor Neoepitope-Based Vaccines: A Scoping Review on Current Predictive Computational Strategies. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39203962 | PubMed |
| 39123454 | Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123454 | PubMed |
| 38098505 | The development of cancers research based on mitochondrial heat shock protein 90. | Front Oncol | 2023 | https://conductscience.org/library/papers/38098505 | PubMed |
| 37508774 | An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/37508774 | PubMed |
| 37213670 | Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition. | Int J Med Sci | 2023 | https://conductscience.org/library/papers/37213670 | PubMed |
| 36528578 | Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non-small-cell lung cancer patients: a prospective observational study. | BMC Cancer | 2022 | https://conductscience.org/library/papers/36528578 | PubMed |
| 36330448 | KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers. | Front Genet | 2022 | https://conductscience.org/library/papers/36330448 | PubMed |
| 36238300 | Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms. | Front Immunol | 2022 | https://conductscience.org/library/papers/36238300 | PubMed |
| 36004014 | KRAS G12C-Mutant Non-Small-Cell Lung Adenocarcinoma: First Documented Report in the Arabian Gulf. | Cureus | 2022 | https://conductscience.org/library/papers/36004014 | PubMed |
| 35441145 | Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration. | RSC Chem Biol | 2022 | https://conductscience.org/library/papers/35441145 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20108024
GET https://conductscience.org/api/papers/v1/20108024/cited_by?page=2